Business News • PR NewsWire • Roxane Laboratories, Inc. Announces the Launch of Losartan Potassium Tablets USP and Losartan Potassium and Hydrochlorothiazide Tablets

Roxane Laboratories, Inc. Announces the Launch of Losartan Potassium Tablets USP and Losartan Potassium and Hydrochlorothiazide Tablets

Roxane Laboratories, Inc. Announces the Launch of Losartan Potassium Tablets USP and Losartan Potassium and Hydrochlorothiazide Tablets

COLUMBUS, Ohio, Oct. 6 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Losartan Potassium Tablets USP, 25mg, 50mg and 100mg as well as Losartan Potassium and Hydrochlorothiazide Tablets, 50mg/12.5mg and 100mg/25mg by the U.S.

View More : http://www.prnewswire.com/news-releases/roxane-laboratories-inc-announces-the-launch-of-losartan-potassium-tablets-usp-a...

Releted News by prnewswire

ARCADIS' U.S. Infrastructure Division Hires Computational Fluid Dynamics Expert John Richardson

Bumper Crop of Ballot Measures Could Signal Major Fiscal Policy Shifts, Report Finds